| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Phr Barrett | Q57560853 |
| Robert A. Hegele | Q58046422 | ||
| Bernard Zinman | Q61337175 | ||
| Anthony J Hanley | Q89837571 | ||
| P2093 | author name string | Henian Cao | |
| Stewart B. Harris | |||
| P2860 | cites work | Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus | Q28251167 |
| Genetic prediction of atherosclerosis: lessons from studies in native Canadian populations | Q33746616 | ||
| HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community | Q34049309 | ||
| Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians | Q34410232 | ||
| Genetic determinants of type 2 diabetes mellitus | Q34421519 | ||
| The prevalence of the HNF-1alpha G319S mutation in Canadian aboriginal youth with type 2 diabetes | Q35009860 | ||
| Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community | Q38553357 | ||
| Overweight among children and adolescents in a Native Canadian community: prevalence and associated factors | Q40775525 | ||
| A common mtDNA polymorphism associated with variation in plasma triglyceride concentration. | Q43104686 | ||
| Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations | Q43546745 | ||
| Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change | Q43748989 | ||
| Factor V Leiden (F5 Q506) and vascular disease in Canadian Oji-Cree | Q47883630 | ||
| -6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree. | Q48019208 | ||
| G protein beta3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. | Q50862344 | ||
| Low dietary fiber and high protein intakes associated with newly diagnosed diabetes in a remote aboriginal community. | Q50919972 | ||
| Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. | Q50956021 | ||
| The prevalence of NIDDM and associated risk factors in native Canadians. | Q50959947 | ||
| NAT2 polymorphism associated with plasma glucose concentration in Canadian Oji-Cree. | Q51556459 | ||
| Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree. | Q51566355 | ||
| Variation in the AU(AT)-Rich Element within the 3'-Untranslated Region of PPP1R3 Is Associated with Variation in Plasma Glucose in Aboriginal Canadians | Q63869180 | ||
| Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes | Q63869185 | ||
| Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations | Q72992423 | ||
| Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians | Q73031211 | ||
| Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians | Q73249289 | ||
| The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree | Q73352602 | ||
| Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians | Q73440402 | ||
| Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree | Q73782595 | ||
| Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians | Q73857628 | ||
| Increasing rates of ischemic heart disease in the native population of Ontario, Canada | Q73935055 | ||
| Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins | Q73965813 | ||
| Gender, obesity, hepatic nuclear factor-1alpha G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree | Q74200433 | ||
| Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations | Q74203401 | ||
| Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree | Q74265922 | ||
| Methylene tetrahydrofolate reductase gene, dietary folate, NIDDM, and atherosclerosis in Canadian Oji-Cree | Q74436722 | ||
| Absence of association between genetic variation of the beta 3-adrenergic receptor and metabolic phenotypes in Oji-Cree | Q74554468 | ||
| Hepatocyte nuclear factor-1 alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes | Q74655549 | ||
| Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetes | Q77351860 | ||
| Hemochromatosis and diabetes mellitus | Q77364147 | ||
| Association between AGT T235 variant and microalbuminuria in Canadian Oji-Cree with type 2 diabetes mellitus | Q77925883 | ||
| Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers | Q77941019 | ||
| The ADD1 G460W polymorphism is not associated with variation in blood pressure in Canadian Oji-Cree | Q78071587 | ||
| Association between AGT codon 235 polymorphism and variation in serum concentrations of creatinine and urea in Canadian Oji-Cree | Q78138896 | ||
| Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers | Q78579798 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| nuclear protein | Q16860021 | ||
| P304 | page(s) | 163-170 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Clinical Biochemistry | Q5133749 |
| P1476 | title | Genes, environment and Oji-Cree type 2 diabetes | |
| P478 | volume | 36 |
| Q42535246 | Atypical diabetes: clarifying the muddy waters |
| Q57945504 | Chapter 1 Transcription factor genes in type 2 diabetes |
| Q38816592 | Complex Genetics of Type 2 Diabetes and Effect Size: What have We Learned from Isolated Populations? |
| Q35964119 | Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes |
| Q36495094 | DNA on loan: issues to consider when carrying out genetic research with aboriginal families and communities |
| Q28078186 | Diabetes mellitus and the Aboriginal diabetic initiative in Canada: An update review |
| Q47259773 | Figuring Out Type 2 Diabetes through Genetic Research: Reckoning Kinship and the Origins of Sickness |
| Q33786252 | HNF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study |
| Q90401365 | Health Challenges of the Pacific Region: Insights From History, Geography, Social Determinants, Genetics, and the Microbiome |
| Q36787559 | Insights on pathogenesis of type 2 diabetes from MODY genetics |
| Q42104171 | Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats. |
| Q35725051 | Kidney disease and youth onset type 2 diabetes: considerations for the general practitioner |
| Q37122916 | Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community |
| Q37820073 | Obesity and type 2 diabetes in Northern Canada's remote First Nations communities: the dietary dilemma |
| Q43052194 | Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome |
| Q36159881 | Traditional food consumption behaviour and concern with environmental contaminants among Cree schoolchildren of the Mushkegowuk territory |
| Q57710254 | Widening inequality in extreme macrosomia between Indigenous and non-Indigenous populations of Québec, Canada |
Search more.